|Articles|September 29, 2004

Master of Antimalarial Resistance

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Copacabana Beach and Ipanema Beach in Rio de Janeiro, Brazil (Adobe Stock 193839900 by f11photo)

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants

ByTori Whitacre Martonicz, MA

August 10th 2026

Paper with urinary tract infection written on it and pills. (Adobe Stock 82815499 by Vitalii Vodolazskyi)

Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs

ByInfection Control Today® Editorial Staff

August 10th 2026

Sick baby boy applying inhaled medication by inhalation mask to cure Respiratory Syncytial Virus (RSV) on the patient's bed at the hospital. (Adobe Stock 262979486 by zilvergolf)

FDA Accepts Merck Application to Expand ENFLONSIA Protection Into Second RSV Season

ByInfection Control Today® Editorial Staff

August 10th 2026

Microscopic view of Cyclospora cayetanensis oocysts under magnification, stained bright red. cyclosporiasis outbreak, foodborne parasites, intestinal infections. water pollution. (Adobe Stock 2122448953 by alones)

Roche Expands Cyclospora PCR Testing Portfolio to Support Ongoing US Outbreak Response

ByInfection Control Today® Editorial Staff

August 7th 2026

Peter Graves, BSN, RN, CNOR Justin McKay Jill Holdsworth, MS, CIC, FAPIC, AL-CIP Tori Whitacre Martonicz, MA

Lead Apron Safety Requires Collaboration Across Infection Prevention, OR, and Radiology Teams

ByTori Whitacre Martonicz, MA

August 7th 2026

Latest CME

Video

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD

Multimedia

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Onyema Ogbuagu, MD, FACP, FIDSA

Master of Antimalarial Resistance

Related Content

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants

Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs

FDA Accepts Merck Application to Expand ENFLONSIA Protection Into Second RSV Season

Roche Expands Cyclospora PCR Testing Portfolio to Support Ongoing US Outbreak Response

Lead Apron Safety Requires Collaboration Across Infection Prevention, OR, and Radiology Teams

Latest CME

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Trending on Infection Control Today

Roche Expands Cyclospora PCR Testing Portfolio to Support Ongoing US Outbreak Response

FDA Accepts Merck Application to Expand ENFLONSIA Protection Into Second RSV Season

Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs

Lead Apron Safety Requires Collaboration Across Infection Prevention, OR, and Radiology Teams

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants